Search by Drug Name or NDC

    NDC 50090-1664-00 NOVOLOG 100 [iU]/mL Details

    NOVOLOG 100 [iU]/mL

    NOVOLOG is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is INSULIN ASPART.

    Product Information

    NDC 50090-1664
    Product ID 50090-1664_b01617ba-efae-44d9-b8ce-15a977d2fed5
    Associated GPIs 27104002002022
    GCN Sequence Number 044340
    GCN Sequence Number Description insulin aspart VIAL 100/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 92326
    HICL Sequence Number 020769
    HICL Sequence Number Description INSULIN ASPART
    Brand/Generic Generic
    Proprietary Name NOVOLOG
    Proprietary Name Suffix n/a
    Non-Proprietary Name insulin aspart
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN ASPART
    Labeler Name A-S Medication Solutions
    Pharmaceutical Class Insulin Analog [EPC], Insulin [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA020986
    Listing Certified Through 2024-12-31

    Package

    NDC 50090-1664-00 (50090166400)

    NDC Package Code 50090-1664-0
    Billing NDC 50090166400
    Package 1 VIAL, GLASS in 1 CARTON (50090-1664-0) / 10 mL in 1 VIAL, GLASS
    Marketing Start Date 2015-01-23
    NDC Exclude Flag N
    Pricing Information N/A